Figure 3.
The crude OS vs expected survival in subgroups with normal life expectancy. (A) Age of ≥70 years (SMR, 1.12; P = .331); (B) stage I disease (SMR, 1.17; P = .184); (C) skin origin (SMR, 1.02; P = .95); and (D) stomach origin (SMR,1.17; P = .455).

The crude OS vs expected survival in subgroups with normal life expectancy. (A) Age of ≥70 years (SMR, 1.12; P = .331); (B) stage I disease (SMR, 1.17; P = .184); (C) skin origin (SMR, 1.02; P = .95); and (D) stomach origin (SMR,1.17; P = .455).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal